Key result
Frailty in CVD patients is linked to ~73% higher 30-day mortality and increased unplanned readmission.
Why the study?
There is limited knowledge on measuring frailty using administrative health data across a wide range of cardiovascular diseases.
Does frailty defined by the hospital frailty risk score (HFRS) predict adverse health outcomes and higher costs in patients with cardiovascular disease?
Cohort
Does frailty defined by the hospital frailty risk score (HFRS) predict adverse health outcomes and higher costs in patients with cardiovascular disease?
Odds Ratio: 1.73
Frailty, as measured by the hospital frailty risk score using administrative data, is significantly associated with increased 30-day mortality, readmission, length of stay, and healthcare costs in patients with diverse cardiovascular diseases.
HFRS-defined frailty was associated with higher 30-day mortality and costs across CVD; extends HF data but leaves open prospective validation before routine use.
BACKGROUND: Despite recent evidence on the effect of frailty on health outcomes among those with heart failure, there is a dearth of knowledge on measuring frailty using administrative health data on a wide range of cardiovascular diseases (CVD). METHODS: We conducted a retrospective record-linkage cohort study of patients with diverse CVD in Queensland, Australia. We investigated the relationship between the risk of frailty, defined using the hospital frailty risk score (HFRS), and 30-day mortality, 30-day unplanned readmission, non-home discharge, length of hospital stay (LOS) at an emergency department and inpatient units and costs of hospitalisation. Descriptive analysis, bivariate logistic regression and generalised linear models were used to estimate the association between HFRS and CVD outcomes. Smear adjustment was applied to hospital costs and the LOS for each frailty risk groups. RESULTS: The proportion of low, medium and high risk of frailty was 24.6%, 34.5% and 40.9%, respectively. The odds of frail patients dying or being readmitted within 30 days of discharge was 1.73 and 1.18, respectively. Frail patients also faced higher odds of LOS, and non-home discharge at 3.1 and 2.25, respectively. Frail patients incurred higher hospital costs (by 42.7-55.3%) and stayed in the hospital longer (by 49%). CONCLUSION: Using the HFRS on a large CVD cohort, this study confirms that frailty was associated with worse health outcomes and higher healthcare costs. Administrative data should be more accessible to research such that the HFRS can be applied to healthcare planning and patient care.
No takes yet. Share an insight, caveat, or question.
Nghiem et al. (2021) conducted a cohort in Cardiovascular diseases (CVD). High risk of frailty (Hospital Frailty Risk Score) vs. Lower risk of frailty was evaluated on 30-day mortality (OR 1.73). Frail patients with cardiovascular disease had significantly higher odds of 30-day mortality (OR 1.73) and 30-day unplanned readmission (OR 1.18).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: